Clinical Trials Logo

Scar clinical trials

View clinical trials related to Scar.

Filter by:

NCT ID: NCT05263713 Active, not recruiting - Scar Clinical Trials

Aesthetic Outcome of Running Subcuticular Suture Versus Running Horizontal Mattress Suture Closure of Linear Wounds on the Trunk and Extremities

Start date: November 1, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether the use of running subcuticular suture versus running horizontal mattress suture for the repair of cutaneous linear wounds on the trunk and extremities affects aesthetic outcomes. The study team will use a split wound model, where half of the wound is repaired with running subcuticular sutures and the other half is repaired with running horizontal mattress sutures. Three-months post-surgery, the scar will be evaluated via the patient observer scar assessment scale (POSAS), a validated scar instrument, as well as the trace-to-tape method, an objective outcome measure for linear postoperative scars. Any adverse events will also be recorded.

NCT ID: NCT05166395 Withdrawn - Scar Clinical Trials

Laser Treated Scars and Optical Coherence Tomography (OCT)

Start date: May 1, 2024
Phase: N/A
Study type: Interventional

The purpose of this research study is to learn about the effects of the 2940 nm Erbium: Yttrium-Aluminum-Garnet (Er:YAG) laser on treating surgical scar using optical coherence tomography, a medical imaging device.

NCT ID: NCT05149118 Completed - Scar Clinical Trials

Effect of PDRN in Post-operative Scars

Start date: February 1, 2019
Phase: Phase 4
Study type: Interventional

The investigators aimed to evaluate the efficacy of PDRN administration in early wound healing phase on prevention of post-operative scars after open thyroidectomy.

NCT ID: NCT05126017 Not yet recruiting - Burns Clinical Trials

Examine the Validity of a Panel of Objective Burn Scar Measurement Tools

BOSS-2
Start date: January 2022
Phase:
Study type: Observational

Reliable scar assessment is essential not only when designing clinical trials to investigate the efficacy of new and existing scar therapies, but also in everyday, clinical practice, to examine the progress of our patients' care. Subjective assessments are extremely important; they demonstrate to the patient the changes and improvements in their scars since the primary burn injury. Nevertheless, clinicians require reliable, validated, and objective tools which can yield measurable and reproducible outcomes. These are ultimately needed to achieve the goal of reducing the physical and psychosocial burden of scarring through compelling research. Previously, a pilot study (BOSS-1) was conducted in 55 patients with post burn hypertrophic scars. The investigators measured, among other parameters, scar thickness, density, and pliability, using a panel of objective scar assessment tools, alongside standard subjective measurements (questionnaire-based), and skin biopsy assessments. Measurements were performed at a single time point which varied from 3 months to 6 years post burn injury. This work indicated that measuring scar thickness, pliability and colour together, may provide a global scar objective score. BOSS-2 is a multi-centre study that will validate the preliminary findings in BOSS-1.

NCT ID: NCT05074238 Recruiting - Wound Heal Clinical Trials

Influence of Sun Protection and Linear Repair of Cutaneous Surgical Defects

Start date: July 16, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the potential influence of sun protection on the aesthetic outcome of post-surgical scars following the reconstruction of Mohs micrographic surgery defects via linear repair. This study will be performed as a randomized split-wound study. Half of the wound will be treated with zinc containing sunscreen and the other half of the wound would not be treated. Three-months post-surgery, the scar will be evaluated via the patient observer scar assessment scale (POSAS), a validated scar instrument, as well as a colorimeter to measure the amount of vascularity, and hyperpigmentation between the treated and the non-treated area compared to the 'surrounding skin' defined as skin in the proximity but not adjacent to the wound. Any adverse events will also be recorded.

NCT ID: NCT05003869 Recruiting - Scar Clinical Trials

Clinical and Basic Research on the Necessity of Scar Tissue Resection During Intrauterine Adhesions

Start date: May 25, 2021
Phase: N/A
Study type: Interventional

TCRA is an important surgical method to restore normal menstrual cycle and improve the outcome of pregnancy.However, postoperative intrauterine adhesion, uterine cavity deformation and difficulty in normal intimal growth seriously affect the efficacy of surgery. A large number of existing studies have shown that even after surgical treatment, women with a history of IUA are still at a reproductive disadvantage.Whether scar tissue plays a role in these influencing factors? At present, there is a variety of surgical methods, and there is no clear guideline consensus on how to deal with intrauterine scar tissue during surgery.

NCT ID: NCT04896346 Active, not recruiting - Scar Clinical Trials

Scarring in Stratagraft-treated vs. Autograft-treated Burn Wounds: a Clinical and Histological Investigation

Start date: February 9, 2022
Phase:
Study type: Observational

The purpose of this study is to describe and better understand the scars of subjects that have been treated with Stratagraft tissue vs autograft.

NCT ID: NCT04870008 Completed - Scar Clinical Trials

Aesthetic Outcome of Running Cuticular Suture Distance (2mm vs 5mm)

Start date: November 20, 2019
Phase: N/A
Study type: Interventional

It is standard teaching that the top layer of sutures should be placed 3-5mm from the wound edge. However, there is lack of data regarding the most optimal placement of sutures from the wound edge for the best cosmetic outcome. The research team wish to determine if sutures placed closer to the wound edge (2mm) or farther from the wound edge (5mm) makes a difference in the cosmetic outcome of the scar.

NCT ID: NCT04736251 Recruiting - Scar Clinical Trials

Mechanistic Basis of Ablative Carbon Dioxide Laser in Treating Hypertrophic Scars

SMOOTH
Start date: December 9, 2019
Phase:
Study type: Observational

This is an observational cohort study which will look at the biomarkers from blood and tissue sample for adult patients with hypertrophic scarring due to burns/trauma incident over 12 months from date of recruitment. The study will assess the kinetics of the response to fractionated carbon dioxide laser therapy in hypertrophic scars.

NCT ID: NCT04621994 Not yet recruiting - Scar Clinical Trials

Cesarean Wound Closure: Dermabond Versus Steri Strips

Start date: November 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to determine overall patient satisfaction with their cesarean section scar with application of Steri-strips vs. Dermabond following subcuticular skin closure of pfannenstiel incision